Cabot (NYSE:CBT) Stock Rating Lowered by Wall Street Zen

Cabot (NYSE:CBT) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

A number of other research analysts have also weighed in on CBT. Mizuho raised their target price on shares of Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. UBS Group raised their target price on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. JPMorgan Chase & Co. raised their target price on shares of Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a report on Wednesday, May 13th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Tuesday, May 26th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cabot currently has an average rating of “Hold” and a consensus target price of $80.25.

Cabot Trading Down 2.6%

Shares of CBT opened at $80.86 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. Cabot has a 1 year low of $58.33 and a 1 year high of $89.46. The company has a 50 day simple moving average of $79.11 and a two-hundred day simple moving average of $73.00. The firm has a market cap of $4.17 billion, a P/E ratio of 15.28, a price-to-earnings-growth ratio of 10.96 and a beta of 0.82.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.31 million. During the same period last year, the firm posted $1.90 EPS. The company’s revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, equities analysts expect that Cabot will post 6.32 earnings per share for the current fiscal year.

Institutional Trading of Cabot

A number of institutional investors have recently bought and sold shares of the stock. Norges Bank purchased a new position in shares of Cabot during the fourth quarter valued at $49,662,000. AQR Capital Management LLC increased its stake in shares of Cabot by 123.0% during the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after buying an additional 478,702 shares during the period. UBS Group AG increased its stake in shares of Cabot by 186.7% during the third quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock valued at $45,136,000 after buying an additional 386,514 shares during the period. Pacer Advisors Inc. increased its stake in shares of Cabot by 3,165.7% during the fourth quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock valued at $15,195,000 after buying an additional 222,232 shares during the period. Finally, American Century Companies Inc. increased its stake in shares of Cabot by 8.4% during the third quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock valued at $137,300,000 after buying an additional 140,665 shares during the period. 93.18% of the stock is currently owned by institutional investors.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.